PCSK9功能丧失变异对LDLR相互作用和动态的影响:对心脏功能的影响
Akanksha Kulshreshtha1, Sonika Bhatnagar1
1Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India.
Biochemical and biophysical research communications
|January 7, 2026
概括
在PCSK9基因中非同义单核酸多态 (nsSNP) 影响心血管风险. 特定的nsSNP,比如在印度发现的A511V,破坏PCSK9-LDLR相互作用的稳定性,这可能解释了改变的脂质调节和高胆固醇.
科学领域:
- 综合生物学 综合生物学
- 遗传学 遗传学 是一个
- 心血管研究研究心血管研究
背景情况:
- 非同义单核酸多态 (nsSNP) 对于理解疾病机制至关重要.
- PCSK9蛋白调节胆固醇;其遗传变异影响心血管疾病 (CVD) 的风险.
- 功能丧失 (LOF) PCSK9突变降低了LDL胆固醇,并防止高胆固醇血症.
研究的目的:
- 研究印度人群中PCSK9 nsSNP对蛋白质稳定性,动态和LDLR相互作用的影响.
- 评估LOF突变对PCSK9-LDLR复合体的结构和动态影响.
主要方法:
- 在野生型和LOF PCSK9-LDLR复合体上进行了分子动力学模拟.
- 分析蛋白质稳定性,动力学和相互作用接口.
主要成果:
- 发现R93C,N298D和A511V突变会破坏PCSK9-LDLR复合物的稳定.
- 印度人群中唯一的A511V变种显示完全失去与LDLR的相互作用.
- LOF变体表现出显著的结构不稳定性,与改变的脂质调节相关.
结论:
- 该研究提供了关于PCSK9 LOF变异的结构后果的见解.
- 这些发现支持了这些变异在改变脂质代谢和高胆固醇血风险中的作用.
- 结果可以帮助预测PCSK9 LOF,促进个性化风险评估和心脏病药物设计.
相关概念视频
Coronary Artery Disease II: Pathophysiology
360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Atherosclerosis I: Introduction
890
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
890
Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580


